The Company

 

The Company

 

Avergen Pharmaceutical GmbH (APG) creates long-term value through internal and collaborative innovative drug discovery programs based on novel drug targets. APG is dedicated on its core competences in neurodegenerative diseases indications. APG is focused on drug development until phase II clinical studies.The location of the company in Munich enables the access to experienced experts in the field of drug discovery and development, as well as business development and commercialization.

 

 

 

 

 

 

 

Avergen Pharmaceuticals GmbH

 

Handelsregister beim Amtsgericht München, Nr. HRB 217756

 

Vertreten wird die Avergen Pharmaceuticals GmbH durch seinen Geschäftsführer:

Dr. med. Murat Yildiz

 

Umsatzsteueridentifikationsnummer: DE300119217

 

Zuständige Aufsichtsbehörde: Regierung von Oberbayern

 

Address:

 

Am Klopferspitz 19

82152 Martinsried

Germany